Does Lamotrigine Cause Headaches? And What to Do About It

Headache is the single most commonly reported side effect of lamotrigine, showing up more often than dizziness, nausea, or rash in clinical trials across both epilepsy and bipolar disorder populations. But the relationship between lamotrigine and headache is more nuanced than a simple cause-and-effect, and the distinction between “reported during treatment” and “actually caused by the drug” turns out to matter quite a bit for understanding your own experience.

How Common Are Lamotrigine Headaches, Really

The headline number is striking: in a pooled analysis of three clinical trials involving the extended-release formulation, about 25% of patients reported headache as a treatment-emergent adverse event. That makes it the most frequently noted complaint, ahead of dizziness at 16%.¹ But there is a catch: when researchers went further and assessed which headaches were “reasonably attributed” to lamotrigine itself, the number dropped sharply to just 6% of patients. Dizziness attributable to the drug was 10%. In other words, about three quarters of the headaches that occurred during treatment were considered incidental rather than drug-caused.

That gap is not unique to lamotrigine. Headache is one of the most common symptoms in the general population, so any long-running clinical trial will accumulate headache reports regardless of what drug is being tested. Still, controlled trials have confirmed that headache does occur more frequently in people taking lamotrigine than in those taking a placebo, so the drug genuinely does raise the odds.² In studies focused on bipolar disorder, headache was again the most common adverse event reported.³ The reassuring detail is that headache seldom led to people stopping the medication. For most, it was an inconvenience that either resolved on its own or was manageable enough to tolerate alongside the drug’s therapeutic benefits.

When Headaches Tend to Show Up

If you are going to get headaches from lamotrigine, the early weeks of treatment are the riskiest window. A pharmacovigilance study looking at adverse drug reactions in children on lamotrigine (and topiramate) found that most adverse reactions appeared early in the treatment course, particularly when lamotrigine was being added on top of another medication.⁴ This pattern aligns with what clinicians generally observe in adults as well: side effects tend to cluster in the dose-escalation phase, when your body is still adapting to the drug.

This matters practically because it means a headache that appears in week two or three of lamotrigine does not necessarily predict a permanent problem. Many people find that headaches fade as they reach their maintenance dose and the body acclimates. On the other hand, a new headache that develops months or years into stable lamotrigine treatment deserves more scrutiny, because a different mechanism may be at work.

Why the Titration Schedule Matters So Much

Lamotrigine is one of several medications where the initial dosing strategy has an outsized influence on side effects. A slow, gradual ramp-up is the standard recommendation, and research strongly supports it. Several commonly used anticonvulsants, lamotrigine among them, produce more severe adverse effects when introduced at their usual daily maintenance doses, but those effects can be “avoided almost entirely” with careful, gradual titration.⁵ The “start low, go slow” approach has been shown to reduce the risk of serious reactions and to improve tolerability for the central-nervous-system-related side effects that lamotrigine is known for, including headache, dizziness, and drowsiness.⁶

Most prescribers follow guidelines that start lamotrigine at 25 mg per day (or even 25 mg every other day, depending on other medications you are taking) and increase over several weeks. If you experience headaches during this ramp-up, it is worth telling your prescriber rather than toughing it out, because the titration schedule can sometimes be adjusted. However, do not slow down or speed up on your own, since the titration schedule also helps prevent the serious skin reactions that lamotrigine is known for.

One question that comes up frequently is whether splitting the dose into two daily administrations rather than one might help with side effects. A study comparing once-daily and twice-daily lamotrigine dosing in newly diagnosed epilepsy patients found no significant difference in either seizure outcomes or adverse effects between the two schedules.⁷ So splitting doses is unlikely to be a headache remedy on its own, though individual responses can vary.

Drug Interactions That Can Shift the Balance

Lamotrigine’s blood levels are sensitive to other medications, and when those levels swing, side effects can follow. Two interactions are worth knowing about because they are common and directly relevant to headache.

The first involves estrogen. Ethinyl estradiol, the synthetic estrogen in many combined hormonal contraceptives, speeds up the breakdown of lamotrigine in the body. One study found that women using ethinyl estradiol had lamotrigine concentration-to-dose ratios roughly 40% lower than controls. Women who switched from estrogen-containing contraceptives to progestogen-only methods saw their lamotrigine levels climb back toward normal.⁸ The estimated drop can be dramatic: lamotrigine concentrations may fall by 50 to 60% when combined with estrogen-containing contraceptives.⁹ This creates a seesaw effect. During the active-pill weeks, lamotrigine levels drop; during the placebo week, levels rebound. Those fluctuations can trigger headaches on both ends: from subtherapeutic levels (and breakthrough symptoms of the underlying condition) during the active-pill week, and from a relative spike in lamotrigine during the off week. If you use hormonal birth control or hormone replacement therapy, your prescriber should be aware so the lamotrigine dose can be adjusted accordingly.

The second interaction to watch involves valproate (brand names include Depakote and Depakene). Valproate inhibits the enzyme that clears lamotrigine, effectively doubling lamotrigine blood levels. Case reports have described patients on long-term combined valproate-lamotrigine therapy who developed late-onset side effects, including headache, vertigo, and even unusual movement disorders, sometimes appearing nine months to two years after the last dose adjustment.¹⁰ This is a reminder that side effects do not always announce themselves right away, especially when two drugs are amplifying each other’s effects.

When a Headache Might Signal Something More Serious

In rare cases, headache during lamotrigine treatment is not a routine side effect but a symptom of aseptic meningitis, an inflammation of the membranes around the brain and spinal cord that is not caused by a bacterial infection. This is uncommon, but it has been reported enough to warrant attention. A case series found an apparent association between lamotrigine use and aseptic meningitis, and nearly 40% of cases in that series had a positive rechallenge, meaning symptoms returned when lamotrigine was restarted after being stopped.¹¹ Additional case reports have confirmed recurrence upon re-exposure to the drug.¹²

The red flags that separate aseptic meningitis from a garden-variety headache are worth knowing. Aseptic meningitis typically produces a severe headache accompanied by a stiff neck, sensitivity to light, fever, nausea, and sometimes confusion. If you experience a headache that feels qualitatively different from a normal headache, particularly one with any of these accompanying symptoms, seek medical attention promptly. Stopping lamotrigine resolves the condition, but the diagnosis is easy to miss because clinicians may not think of a medication as the cause of meningitis symptoms.

The Paradox: Lamotrigine as a Headache Treatment

Here is where the story gets interesting. Despite being a known headache trigger, lamotrigine is itself used to treat certain headache disorders, and it performs well in those roles.

The best-studied application is in migraine with aura. A retrospective study comparing lamotrigine to topiramate (a more established migraine preventive) found that lamotrigine was at least as effective for reducing aura frequency and duration. Among lamotrigine-treated patients, 88% were responders for aura frequency compared with 79% in the topiramate group, and half of the lamotrigine patients reported their migraine aura disappearing entirely versus 37% on topiramate. Side effects were also significantly less frequent in the lamotrigine group.¹³ Lamotrigine is thought to work here by suppressing cortical spreading depression, the wave of abnormal brain activity that underlies the aura phenomenon. It does not seem to help much with migraine without aura, which is why it is not a first-line migraine drug overall.

Lamotrigine has also shown promise in a rare but excruciating headache condition called SUNCT syndrome (short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing). Case reports and observational studies have documented decreased frequency and even complete resolution of SUNCT attacks with lamotrigine.¹⁴ In one small study, three of five SUNCT patients achieved complete remission on lamotrigine doses of 125 to 200 mg daily, and the other two experienced about an 80% reduction in attack frequency.¹⁵

The practical upshot is that if you are taking lamotrigine for epilepsy or bipolar disorder and you also have migraine with aura, the drug might actually be pulling double duty and helping both conditions. Conversely, if you develop new headaches on lamotrigine that feel migrainous without aura features, they are less likely to be something the drug will eventually help with on its own.

Sleep Disruption as an Indirect Route to Headaches

One often-overlooked pathway connects lamotrigine to headache indirectly: through disrupted sleep. Among 109 patients studied for lamotrigine-related insomnia, about 6% developed sleep disturbances severe enough to require a therapy change. The insomnia appeared to be dose-dependent, meaning higher doses made it worse.¹⁶ Poor sleep is one of the most reliable headache triggers across the general population, so it is plausible that some lamotrigine-associated headaches are not a direct pharmacological effect but a downstream consequence of sleep loss.

If you notice that your headaches track with poor sleep quality rather than with dose changes or specific times of day, this may be the link. Practical steps include taking lamotrigine earlier in the day (morning rather than evening), discussing dose adjustments with your prescriber, and maintaining standard sleep hygiene habits. Some people find that the insomnia resolves after a few weeks, while for others it persists and requires either a dose reduction or the addition of a sleep aid.

What to Actually Do About Lamotrigine Headaches

The approach depends on when the headaches appeared and how severe they are. For headaches during the initial titration phase, patience is often the best first move, since these frequently resolve as your body adjusts. Over-the-counter pain relievers can bridge the gap, though you should avoid using them daily for more than a few days to prevent medication-overuse headache, which would create a separate problem on top of the lamotrigine issue.

If headaches persist beyond the titration period at a stable dose, a few strategies are worth discussing with your prescriber:

Dose timing: Shifting when you take your dose (morning vs. evening) can sometimes change the side-effect profile, particularly if insomnia is contributing.
Drug-interaction check: Estrogen-containing contraceptives and valproate both alter lamotrigine levels in ways that can produce side effects. Adjusting these co-medications or accounting for them in your lamotrigine dose may help.
Hydration and lifestyle factors: Lamotrigine does not have strong dehydrating effects on its own, but if you are not drinking enough water or are skipping meals during the adjustment period, you are stacking ordinary headache triggers on top of a pharmacological one.
Dose reduction: If headaches are clearly dose-related and intolerable, your prescriber may be able to lower the dose while maintaining therapeutic benefit, though this depends on the condition being treated.

What you should not do is abruptly stop lamotrigine because of headaches. Sudden discontinuation of any anticonvulsant can trigger rebound seizures in people with epilepsy or mood destabilization in people with bipolar disorder. If the headaches are severe enough that you are considering stopping, contact your prescriber so they can taper the dose safely.

Brand-Name Versus Generic Lamotrigine

A question that circulates in patient communities is whether switching between brand-name and generic lamotrigine (or between different generic manufacturers) can trigger headaches. The concern is understandable: anticonvulsants have narrow therapeutic windows, and even small differences in absorption could theoretically cause symptoms. A cohort-crossover study of Medicaid patients who switched from brand to generic lamotrigine found no statistically significant increase in emergency department visits, hospitalizations, or condition-specific encounters after conversion.¹⁷ At a population level, generic lamotrigine appears equivalent.

That said, individual variation exists, and regulatory standards permit small differences in bioavailability between generics and the brand. If you notice a pattern of headaches coinciding with a pharmacy switch to a different manufacturer, it is worth mentioning to your prescriber. Some people do better when they consistently receive the same manufacturer’s product, and pharmacies can sometimes accommodate this request. The evidence does not support the idea that generics are broadly inferior, but it also does not rule out that a specific person might respond differently to formulation changes.

Conditions That Mimic Lamotrigine-Induced Headache

Before attributing a persistent headache to lamotrigine, it helps to rule out other possibilities. Tension headaches and migraines are extremely common in the populations that take lamotrigine. Epilepsy itself is associated with higher rates of comorbid migraine. Bipolar disorder, the other major indication for lamotrigine, frequently co-occurs with chronic pain conditions. And stress, which often accompanies the adjustment to a new medication or the management of a chronic neurological or psychiatric condition, is a universal headache trigger.

A headache diary can be a surprisingly useful tool for sorting this out. Track when headaches occur, their intensity, their character (throbbing, pressing, one-sided, all-over), what you ate and drank, how you slept, and where you are in your lamotrigine titration schedule. Patterns tend to emerge quickly. If headaches cluster around dose increases and fade in between, lamotrigine is a likely contributor. If they track more closely with sleep quality, stress, or menstrual cycles, the drug may be a bystander rather than the culprit. Bringing this kind of data to your prescriber makes the conversation far more productive than a vague report of “I’m getting headaches.”